To the Editor We read with great interest the research letter from Chauhan et al1 regarding the topic of surgical intervention in facial nonmelanoma skin cancer (fNMSC). The authors propose that age older than 90 years should be a relative contraindication for the treatment of fNMSC based on (1) the percentage of no residual carcinoma following excision (35.3% in the study) and (2) patient longevity. We agree these claims warrant further discussion; however, several points need clarification.
Hill D, Mansouri B, Housewright C. Age and Treatment of Nonmelanoma Skin Cancer. JAMA Surg. 2018;153(9):866–867. doi:10.1001/jamasurg.2018.1676
Artificial Intelligence Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.